ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir — plaquette(s) polyamide aluminium PVC de 60 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930277133
  • CIP7 3027713
  • CIS 61428656
  • Registration number EU/1/15/1058

What the source publishes

Holder
NOVARTIS EUROPHARM (IRLANDE)
Active ingredients
VALSARTAN, COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ, SACUBITRIL
Form
granulés en gélule
Package
plaquette(s) polyamide aluminium PVC de 60 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2023-05-26
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930277133
{
  "cis": "61428656",
  "cip7": "3027713",
  "form": "granulés en gélule",
  "name": "ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir — plaquette(s) polyamide aluminium PVC de 60 gélule(s)",
  "cip13": "3400930277133",
  "holder": "NOVARTIS EUROPHARM (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "NOVARTIS EUROPHARM (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "118.86",
  "authorisedOn": "2023-05-26",
  "compositions": [
    {
      "name": "VALSARTAN",
      "nature": "FT",
      "strength": "16,07 mg",
      "linkageNumber": "1",
      "substanceCode": "15734",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "granulés"
    },
    {
      "name": "COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "16541",
      "dosageReference": null,
      "pharmaceuticalElement": "granulés"
    },
    {
      "name": "SACUBITRIL",
      "nature": "FT",
      "strength": "15,18 mg",
      "linkageNumber": "1",
      "substanceCode": "78789",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "granulés"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "117.84",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) polyamide aluminium PVC de 60 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2024-07-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "VALSARTAN",
    "COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ",
    "SACUBITRIL"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/15/1058",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930277133"